Neogen Chemicals Live Share Price Today, Share Analysis and Chart

Monitoring agency report for the quarter ended September 30, 2026 i.r.o. QIP of Rs. 600 crores.

Earnings call recording Q2 H1 FY 2027

Specialty Chemicals company Neogen Chemicals announced Q2FY27 results Consolidated Financial Highlights: Revenue from operations: For Q2FY27, consolidated revenue from operations stood at Rs 295.96 crore, showing an increase of 18.25% QoQ from Rs 250.29 crore in Q1FY27 and a growth of 41.84% YoY against Rs 208.66 crore in Q2FY26. For H1FY27, consolidated revenue from operations reached Rs 546.25 crore, recording an expansion of 38.16% YoY from Rs 395.38 crore in H1FY26. Total income: For Q2FY27, consolidated total income was Rs 299.92 crore, up by 18.01% QoQ compared to Rs 254.15 crore in Q1FY27 and increasing by 42.45% YoY compared to Rs 210.55 crore in Q2FY26. For H1FY27, consolidated total income reached Rs 554.07 crore, up 39.06% YoY against Rs 398.45 crore in H1FY26. Profit before tax (PBT): For Q2FY27, consolidated profit before tax was Rs 12.72 crore, down by 45.36% QoQ from Rs 23.28 crore in Q1FY27, but up by 146.99% YoY over Rs 5.15 crore in Q2FY26. For H1FY27, consolidated profit before tax stood at Rs 36.00 crore, escalating by 85.09% YoY from Rs 19.45 crore in H1FY26. Profit after tax (PAT): For Q2FY27, consolidated profit after tax was Rs 8.23 crore, down 51.90% QoQ from Rs 17.11 crore in Q1FY27, but growing by 144.21% YoY from Rs 3.37 crore in Q2FY26. For H1FY27, consolidated profit after tax stood at Rs 25.34 crore, indicating a growth of 85.64% YoY over Rs 13.65 crore in H1FY26. Earnings per share (EPS): For Q2FY27, consolidated basic and diluted EPS was Rs 2.96, declining by 52.94% QoQ from Rs 6.29 in Q1FY27, but increasing by 131.25% YoY against Rs 1.28 in Q2FY26. For H1FY27, consolidated basic and diluted EPS stood at Rs 9.21, reflecting a growth of 77.80% YoY compared to Rs 5.18 in H1FY26. Standalone Financial Highlights: Revenue from operations: For Q2FY27, standalone revenue from operations reached Rs 288.00 crore, representing a growth of 14.16% QoQ from Rs 252.28 crore in Q1FY27 and an expansion of 39.35% YoY against Rs 206.68 crore in Q2FY26. For H1FY27, standalone revenue from operations recorded Rs 540.28 crore, achieving a growth of 38.09% YoY over Rs 391.26 crore in H1FY26. Total income: For Q2FY27, standalone total income was Rs 296.28 crore, showing an uptick of 13.88% QoQ over Rs 260.18 crore in Q1FY27 and up by 40.38% YoY over Rs 211.05 crore in Q2FY26. For H1FY27, standalone total income stood at Rs 556.46 crore, higher by 39.48% YoY compared to Rs 398.94 crore in H1FY26. Profit before tax (PBT): For Q2FY27, standalone profit before tax stood at Rs 28.43 crore, rising by 8.80% QoQ from Rs 26.13 crore in Q1FY27 and rising by 130.58% YoY from Rs 12.33 crore in Q2FY26. For H1FY27, standalone profit before tax was Rs 54.55 crore, jumping by 73.67% YoY from Rs 31.41 crore in H1FY26. Profit after tax (PAT): For Q2FY27, standalone profit after tax recorded Rs 21.14 crore, expanding by 8.74% QoQ over Rs 19.44 crore in Q1FY27 and climbing by 127.07% YoY over Rs 9.31 crore in Q2FY26. For H1FY27, standalone profit after tax reached Rs 40.58 crore, escalating by 72.31% YoY against Rs 23.55 crore in H1FY26. Earnings per share (EPS): For Q2FY27, standalone basic and diluted EPS was Rs 7.60, expanding by 6.29% QoQ compared to Rs 7.15 in Q1FY27 and rising by 115.30% YoY compared to Rs 3.53 in Q2FY26. For H1FY27, standalone basic and diluted EPS stood at Rs 14.75, which is a growth of 65.17% YoY from Rs 8.93 in H1FY26. Harin Kanani, Managing Director, Neogen Chemicals, said: “We have delivered a robust all-round performance, demonstrating remarkable agility despite a challenging macroeconomic backdrop marked by geopolitical conflicts, supply chain friction, feedstock cost inflation, and the temporary unavailability of our Dahej facility. This performance underscores the resilience of our business model, as we swiftly pivoted toward applications with better demand visibility and higher volumes. This momentum was further reinforced by accelerated ramp-up in our Battery Chemicals business. In our Battery Chemicals business, we are transitioning from capital investment to the execution and ramp-up phase. We continue to deepen our engagement with leading domestic and global cell manufacturers for supply of electrolyte and lithium salts. With upcoming ACC battery manufacturing plants coming online in India and a progressive shift by US electrolyte manufacturers toward sourcing from non-FEOC suppliers from India, we expect a substantial scale-up in Q4FY27 and beyond. Our dual facilities at Dahej SEZ and Pakhajan are uniquely positioned to cater to these accelerated requirements, establishing Neogen as one of the largest Indian battery component manufacturers. A key strategic milestone during the period was the successful completion of our maiden QIP, raising Rs 600 crore, which was oversubscribed 6.5x, drawing strong participation from marquee domestic and global institutional investors. This overwhelming response serves as a strong endorsement of market confidence in our long-term growth story. The proceeds are being strategically deployed toward de-leveraging our balance sheet, preparing for funding incremental business requirements and growth initiatives. Regarding our Dahej facility insurance claims, we are pleased to share that the majority of the recognized claim amount has already been received through successive on-account payouts. Discussions with the insurers for the remaining balance are progressing constructively, and we expect further settlements in due course as the final assessments conclude. Looking ahead, the outlook for both Neogen Standalone and our Battery Chemicals business remains encouraging as we enter the next phase of transformational growth, supporting India’s vision for self-reliance in the energy storage and advanced battery materials ecosystem. Guided by a clear execution roadmap and supported by a strengthened balance sheet, our full-year consolidated guidance remains on track as we stay focused on driving sustainable growth and delivering long-term value for our stakeholders.” Result PDF

Earnings Presentation for the quarter and half year ended 30-09-2026

Press Release for the Quarter and half year ended 30-09-2026.